RadNet EBITDA 2010-2024 | RDNT

RadNet EBITDA for the quarter ending September 30, 2024 was $0.086B, a 7.4% decline year-over-year.

  • RadNet 2023 EBITDA was 0.295B, a 24.12% increase from 2022.
  • RadNet 2022 EBITDA was 0.237B, a 8.72% decline from 2021.
  • RadNet 2021 EBITDA was 0.26B, a 31.23% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

RadNet EBITDA 2010-2024 | RDNT

  • RadNet 2023 EBITDA was 0.295B, a 24.12% increase from 2022.
  • RadNet 2022 EBITDA was 0.237B, a 8.72% decline from 2021.
  • RadNet 2021 EBITDA was 0.26B, a 31.23% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$19.5B
Quest Diagnostics (DGX)$18B
DaVita (DVA)$12.9B
Encompass Health (EHC)$10B
Chemed (CHE)$8.2B
Elanco Animal Health (ELAN)$6.6B
Option Care Health (OPCH)$3.7B
Amedisys (AMED)$2.9B
LifeStance Health (LFST)$2.8B
Astrana Health (ASTH)$2.3B
Addus HomeCare (ADUS)$2.2B
U.S Physical Therapy (USPH)$1.4B
Aveanna Healthcare Holdings (AVAH)$1.1B
Pennant (PNTG)$1.1B
Atai Life Sciences (ATAI)$290M
Daxor (DXR)$43M
MEDIROM Healthcare Technologies (MRM)$15M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$8M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M